L Mizen
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 15
- Pharmacogenetics and Drug Metabolism 2
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- R. Sutherland (1 shared paper)Gary Woodnutt (10 shared papers)C. Edward Dixon (1 shared paper)P. Acred (3 shared papers)Valerie Berry (4 shared papers)James Clayton (2 shared papers)Martin Cole (2 shared papers)Stephen W. Elson (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Journal of Antimicrobial Chemotherapy (3 papers)Journal of Medicinal Chemistry (2 papers)Journal of Pharmacy and Pharmacology (1 paper)The Journal of Physiology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
L Mizen
23 papers receiving 334 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 93
- Pharmacology 161
- Clinical Biochemistry 39
- Applied Microbiology and Biotechnology 8
- Pharmaceutical Science 21
Countries citing papers authored by L Mizen
This map shows the geographic impact of L Mizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Mizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Mizen more than expected).
Fields of papers citing papers by L Mizen
This network shows the impact of papers produced by L Mizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Mizen. The network helps show where L Mizen may publish in the future.
Co-authors
The 20 scholars most cited alongside L Mizen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1977 | 95 | |
| 2 | 1976 | 34 | |
| 3 | 1975 | 30 | |
| 4 | 1977 | 29 | |
| 5 | -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation. | 1970 | 27 |
| 6 | 1970 | 23 | |
| 7 | 1991 | 20 | |
| 8 | 1992 | 18 | |
| 9 | 1989 | 17 | |
| 10 | 1995 | 15 | |
| 11 | 1988 | 15 | |
| 12 | 1998 | 13 | |
| 13 | 2006 | 13 | |
| 14 | 1988 | 12 | |
| 15 | 1992 | 9 | |
| 16 | 1987 | 6 | |
| 17 | 1995 | 5 | |
| 18 | 2012 | 3 | |
| 19 | 1966 | 3 | |
| 20 | 1990 | 2 |
About L Mizen
L Mizen is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Infectious Diseases and Molecular Biology, having authored 25 papers that have together received 397 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (9 papers), Infective Endocarditis Diagnosis and Management (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). The work is most often cited by research in Molecular Medicine (93 citations), Pharmacology (161 citations), Clinical Biochemistry (39 citations), Applied Microbiology and Biotechnology (8 citations) and Pharmaceutical Science (21 citations). L Mizen has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include R. Sutherland, Gary Woodnutt, C. Edward Dixon, P. Acred, Valerie Berry, James Clayton, Martin Cole, Stephen W. Elson, George Burton and D. M. Brown. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Medicinal Chemistry, Journal of Pharmacy and Pharmacology and The Journal of Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.